This Company Raised $27 Million for a Weight Loss Balloon You Can Swallow in a Pill
FORTUNE – Beyond diet and exercise, Americans who need to lose significant weight—whether to guard against diabetes, heart disease, or other obesity-related illnesses—don’t have a lot of ideal options. Bariatric surgery is invasive, risky, and expensive.
Allurion Raises $27 Million for Weight-Loss Tech
WSJ – Startup’s balloon-based system delivers weight loss without surgery
Swallowable gastric balloon could help the obese lose weight without surgery
THE GUARDIAN – Although not a replacement for bariatric surgery, temporary balloon could be used as early intervention or for those who do not want, or cannot have, surgery
Allurion Repays Massachusetts Life Sciences Center
MLSC – The Massachusetts Life Sciences Center (MLSC) and Natick-based Allurion Technologies announced that the company, which was awarded a $750,000 Accelerator loan from the MLSC in 2011, has repaid the loan with interest after a successful funding round from private investors.
More Data on Balloon-in-a-Pill Show Almost 15% Weight Loss
MEDSCAPE – Results from another small trial with a novel intragastric balloon that can be swallowed without the patient requiring endoscopy or anesthesia show that the 42 participants lost an average of 15.6 kg (34 lb), or over 14% of their body weight, over the 16-week duration of the trial.
The patients involved in the study had an average BMI of 38.6 kg/m2 at the start of the study and in this case were put on a ketogenic, very low-calorie diet (700 kcal/day) diet for the last 4 weeks of the trial.
Number To Know…10
MEDTECH INSIGHT – 10 minutes is the time it takes to prep the non-surgical, ingestible Elipse gastric balloon for obesity treatment. Elipse is developed by Allurion Technologies, which just bagged $19m in new funding.